LP
DXCM icon

Longaeva Partners’s DexCom DXCM Stock Holding History

Longaeva Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.48M Buy
+135,000
New +$9.4M 0.31% 78

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Longaeva Partners's DXCM Position: Q1 2026 in Review

Longaeva Partners opened a new position in DexCom (DXCM) in Q1 2026: 135,000 shares worth $8.48M. The stake represents 0.31% of the portfolio and ranks #78 among its holdings.

956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Longaeva Partners held 135,000 shares of DexCom worth $8.48M as of Q1 2026.
  • DexCom was a new Longaeva Partners position in Q1 2026.
  • DexCom made up 0.31% of Longaeva Partners's portfolio in Q1 2026, its #78 holding.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Longaeva Partners's 13F filing for Q1 2026, filed 15 May 2026.